Learning Objectives:

  • Gut Microbes and microbial products regulate anti-tumor immunity by modulating the expression T-cell co-inhibitory molecules
  • Targeting PD-L2/RGMb pathway can overcome microbiome-dependent resistance to immunotherapy 
  • RGMb is a novel inhibitory pathway for T cell responses to tumors
Session date: 
01/22/2024 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jon Seok Park, PhD